4-[[9-(2-methoxyspiro[2.5]octan-6-yl)-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol
C26H31F3N6O2 — CID 143262169
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[9-(2-methoxyspiro[2.5]octan-6-yl)-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol
4-[[9-(2-methoxyspiro[2.5]octan-6-yl)-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol (PubChem CID 143262169) has the molecular formula C26H31F3N6O2 and a molecular weight of 516.57 g/mol. Its IUPAC name is 4-[[9-(2-methoxyspiro[2.5]octan-6-yl)-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol.
Molecular Properties
| Compound Name | 4-[[9-(2-methoxyspiro[2.5]octan-6-yl)-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol |
|---|---|
| PubChem CID | 143262169 |
| Molecular Formula | C26H31F3N6O2 |
| Molecular Weight | 516.57 g/mol |
| Exact Mass | 516.25 |
| IUPAC Name | 4-[[9-(2-methoxyspiro[2.5]octan-6-yl)-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol |
| SMILES | COC1CC12CCC(n1c(Nc3c(F)cc(F)cc3F)nc3cnc(NC4CCC(O)CC4)nc31)CC2 |
| InChI | InChI=1S/C26H31F3N6O2/c1-37-21-12-26(21)8-6-16(7-9-26)35-23-20(13-30-24(34-23)31-15-2-4-17(36)5-3-15)32-25(35)33-22-18(28)10-14(27)11-19(22)29/h10-11,13,15-17,21,36H,2-9,12H2,1H3,(H,32,33)(H,30,31,34) |
| InChIKey | LCQKXMWRYDDWSR-UHFFFAOYSA-N |
| XLogP | 5.22 |
| TPSA | 97.12 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 516.57 |
| LogP ≤ 5 | 5.22 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143262169 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.